88
Views
15
CrossRef citations to date
0
Altmetric
Original Research

LncRNA PROX1-AS1 Facilitates Gastric Cancer Progression via miR-877-5p/PD-L1 Axis

, , , , & ORCID Icon
Pages 2669-2680 | Published online: 19 Mar 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Chao He, Yuanyuan Liu, Jinhou Li, Xiao Zheng, Jianwei Liang, Gang Cui & Hong Chang. (2022) LncRNA RPSAP52 promotes cell proliferation and inhibits cell apoptosis via modulating miR-665/STAT3 in gastric cancer. Bioengineered 13:4, pages 8699-8711.
Read now
Bin Yang, Huifeng Diao, Pu Wang, Fengju Guan & Hechen Liu. (2021) microRNA-877-5p exerts tumor-suppressive functions in prostate cancer through repressing transcription of forkhead box M1. Bioengineered 12:1, pages 9094-9102.
Read now

Articles from other publishers (13)

HuSheng Shan, XiaoBo Zhang, Xiao Zhang, YingTian Wei, LiangLiang Meng, Jing Li, ZhongLiang Zhang, Li Ma & YueYong Xiao. (2023) CircSCUBE3 Reduces the Anti-gastric Cancer Activity of Anti-PD-L1. Molecular Biotechnology 66:1, pages 123-137.
Crossref
Jian-sheng Li, Tong-ming Liu, Li Li & Chuan Jiang. (2023) LncRNA PROX1 antisense RNA 1 promotes PD-L1-mediated proliferation, metastasis, and immune escape in colorectal cancer by interacting with miR-520d. Anti-Cancer Drugs 34:5, pages 669-679.
Crossref
Chenxi Zhang, Ying Zhou, Bin Zhang, Zhihong Sheng, Nan Sun, Baiyin Yuan & Xiaoyuan Wu. (2023) Identification of lncRNA, miRNA and mRNA expression profiles and ceRNA Networks in small cell lung cancer. BMC Genomics 24:1.
Crossref
Qiang Zhang, Chuanchi Wang, Yan Yang, Ruihan Xu & Ziyun Li. (2023) LncRNA and its role in gastric cancer immunotherapy. Frontiers in Cell and Developmental Biology 11.
Crossref
Mahmoud Kandeel, Duaa Althumairy, Ibrahim M. El-Sabagh, Saad Shousha, Yehia Hussin, Ahmed M. A. Meligy, Mohamed K. Zabady, Khaled M. Zahran, Nawal Elkhair, Abdulrahman Hereba, Mahmoud G. Elsebaei, Aliya Elamin, Faiza Irshad, Muhammad Sufyan, El-Awad M. El-Hassan & Ibrahim Albokhadaim. (2023) The Interaction of Programmed Cell Death Protein and Its Ligands with Non-Coding RNAs in Neoplasms: Emerging Anticancer Immunotherapeutics. Processes 11:2, pages 538.
Crossref
Milad Rafat, Mahdis Kohsarian, Mohamad Bahiraei & AminR Nikpoor. (2023) A comprehensive study on signal transduction and therapeutic role of miR-877 in human cancers. Advanced Biomedical Research 12:1, pages 118.
Crossref
Jing Liu, Wei Zhan, Gang Chen, Shunkang Yan, Wen Chen & Rui Li. (2023) SP1-induced PROX1-AS1 contributes to tumor progression by regulating miR-326/FBXL20 axis in colorectal cancer. Cellular Signalling 101, pages 110503.
Crossref
E. A. Vetchinkina, A. I. Kalinkin, E. B. Kuznetsova, A. E. Kiseleva, E. A. Alekseeva, M. V. Nemtsova & I. V. Bure. (2022) Diagnostic and prognostic value of long non-coding RNA PROX1‑AS1 and miR-647 expression in gastric cancer. Advances in Molecular Oncology 9:4, pages 50-60.
Crossref
Yingzi Zhang, Yan Yang, Yiran Chen, Wu Lin, Xiangliu Chen, Jin Liu, Yingying Huang, Haiyong Wang & Lisong Teng. (2022) PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer. Frontiers in Immunology 13.
Crossref
Soudeh Ghafouri-Fard, Hamed Shoorei, Bashdar Mahmud Hussen, Yadollah Poornajaf, Mohammad Taheri & Guive Sharifi. (2022) Interplay between programmed death-ligand 1 and non-coding RNAs. Frontiers in Immunology 13.
Crossref
Jun Ma, Quanxing Li & Yuling Li. (2022) CircRNA PRH1‐PRR4 stimulates RAB3D to regulate the malignant progression of NSCLC by sponging miR ‐877‐5p . Thoracic Cancer 13:5, pages 690-701.
Crossref
Weiguo Ma, Yun Gao, Junhua Zhang, Xiaobin Yao, Lina Jia & Qingxia Xu. (2021) Long noncoding RNA LINC01410 promotes tumorigenesis of osteosarcoma cells via miR‐497‐5p/HMGA2 axis. Journal of Biochemical and Molecular Toxicology 35:12.
Crossref
Alex C. H. Wong & John E. J. Rasko. (2021) Splice and Dice: Intronic microRNAs, Splicing and Cancer. Biomedicines 9:9, pages 1268.
Crossref